GeneDx Holdings (WGS) Equity Ratio (2020 - 2026)

GeneDx Holdings (WGS) has 7 years of Equity Ratio data on file, last reported at 0.5 in Q1 2026.

• Equity Ratio for Q1 2026 came in at 0.5, down 12.95% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.5 (down 12.95% YoY), and the FY2025 annual result was 0.59, up 0.63% from the prior year.
• Equity Ratio fell to 0.5 in Q1 2026 per WGS's latest filing, from 0.59 in the prior quarter.
• Over five years, Equity Ratio peaked at 0.68 in Q2 2022 and troughed at 0.5 in Q2 2024.
• A 5-year average of 0.58 and a median of 0.59 in 2025 frame the typical range for Equity Ratio.
• On a YoY basis, Equity Ratio climbed as much as 126.74% in 2022 and fell as far as 26.22% in 2022.
• A 5-year view of Equity Ratio shows it stood at 0.52 in 2022, then increased by 5.37% to 0.54 in 2023, then advanced by 7.4% to 0.58 in 2024, then rose by 0.63% to 0.59 in 2025, then declined by 14.71% to 0.5 in 2026.
• Business Quant data shows WGS's Equity Ratio at 0.5 in Q1 2026, 0.59 in Q4 2025, and 0.59 in Q3 2025.